Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708)

Jian Cui; Lin Yang; Lei Guo; Yongfu Shao; Dongfeng Tan; Ni Li; Haizeng Zhang

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708)

Jian Cui, Lin Yang, Lei Guo, Yongfu Shao, Dongfeng Tan, Ni Li, Haizeng Zhang

Pathology, Anatomical

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

This article has been corrected: The correct author and affiliation information is given below: Jian Cui1, Lin Yang2, Lei Guo2, Yongfu Shao1, Dongfeng Tan3, Ni Li4 and Haizeng Zhang1 1 Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 3 Department of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 4 National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Original language	English (US)
Pages (from-to)	1539
Number of pages	1
Journal	Oncotarget
Volume	10
Issue number	15
State	Published - Feb 1 2019

ASJC Scopus subject areas

Oncology

Fingerprint

Dive into the research topics of 'Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708)'. Together they form a unique fingerprint.

Cite this

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708). / Cui, Jian; Yang, Lin; Guo, Lei et al.
In: Oncotarget, Vol. 10, No. 15, 01.02.2019, p. 1539.

Research output: Contribution to journal › Comment/debate › peer-review

@article{a45f8845274048b88bbb4ddee02f5e9d,

title = "Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708)",

abstract = "This article has been corrected: The correct author and affiliation information is given below: Jian Cui1, Lin Yang2, Lei Guo2, Yongfu Shao1, Dongfeng Tan3, Ni Li4 and Haizeng Zhang1 1 Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 3 Department of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 4 National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.",

author = "Jian Cui and Lin Yang and Lei Guo and Yongfu Shao and Dongfeng Tan and Ni Li and Haizeng Zhang",

note = "Publisher Copyright: {\textcopyright} Cui et al.",

year = "2019",

month = feb,

day = "1",

language = "English (US)",

volume = "10",

pages = "1539",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "15",

}

TY - JOUR

T1 - Correction

T2 - The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708)

AU - Cui, Jian

AU - Yang, Lin

AU - Guo, Lei

AU - Shao, Yongfu

AU - Tan, Dongfeng

AU - Li, Ni

AU - Zhang, Haizeng

PY - 2019/2/1

Y1 - 2019/2/1

N2 - This article has been corrected: The correct author and affiliation information is given below: Jian Cui1, Lin Yang2, Lei Guo2, Yongfu Shao1, Dongfeng Tan3, Ni Li4 and Haizeng Zhang1 1 Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 3 Department of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 4 National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

AB - This article has been corrected: The correct author and affiliation information is given below: Jian Cui1, Lin Yang2, Lei Guo2, Yongfu Shao1, Dongfeng Tan3, Ni Li4 and Haizeng Zhang1 1 Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 3 Department of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 4 National Office for Cancer Prevention and Control, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

UR - http://www.scopus.com/inward/record.url?scp=85061783117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061783117&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 30863500

AN - SCOPUS:85061783117

SN - 1949-2553

VL - 10

SP - 1539

JO - Oncotarget

JF - Oncotarget

IS - 15

ER -

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy (Oncotarget (2017) 8 (37845-37854) DOI: 10.18632/oncotarget.14708)

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this